BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

Progyny (PGNY)ProgynyEarnings

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026.

Related news

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

COOThe Cooper Companies2025-11-04 21:15 EST

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

SERASera Prognostics2026-03-18 20:05 EST

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

TDOCTeladoc2026-02-25 21:05 EST

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

COOThe Cooper Companies2025-12-04 21:15 EST

CooperCompanies Announces Fourth Quarter and Full Year 2025 Results

FEMYFEMASYS2026-08-14 20:05 EST

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

FEMYFEMASYS2026-05-08 20:05 EST

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

HSTMHealthStream2026-02-23 21:30 EST

HealthStream Announces Fourth Quarter & Full-Year 2025 Results

HSTMHealthStream2026-02-12 14:25 EST

HealthStream to Host Fourth Quarter & Full-Year 2025 Earnings Conference Call

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-11-04 21:01 EST

Progyny, Inc. Announces Third Quarter 2026 Results

PGNYProgyny2026-10-28 13:52 EST

New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

PGNYProgyny2026-10-26 15:25 EST

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2026-10-15 13:35 EST

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Stock data

Close
34.37 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States